Plus   Neg

Stock Alert: CryoLife Rises 6%

Shares of CryoLife Inc. (CRY) are rising more than 6 percent or $1.01 in Friday's morning trade at $17.75 despite no company-centric news that could move the stock.

U.S. stocks are little changed on Friday with traders seemingly reluctant to make significant moves following the substantial volatility seen over the past several sessions. While the Federal Reserve indicated it plans to leave interest rates at near-zero levels for years to come, traders seem skeptical that will be enough to support the economy.

Kennesaw, Georgia-based CryoLife is a maker of medical devices and implantable human tissues.

CryoLife has traded in a range of $12.63 to $31.77 in the past 52 weeks.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Telecom giant AT&T, Inc. reported Thursday a 24 percent decline in profit for the third quarter, primarily hurt by lower revenues across all its operating segments amid the impact from COVID-19 pandemic. Adjusted earnings for the quarter met analysts' expectations, while quarterly revenues topped their estimates. A Brazilian volunteer, who participated in a clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University, has died, Brazilian health authority Anvisa said. Oxford university reportedly confirmed the plan to continue the trial after careful assessment that there have been no concerns about safety of the clinical trial. NASA's Osiris-Rex robotic spacecraft briefly touched down on near-Earth asteroid Bennu's surface on Tuesday to collect rock and dust samples that will be brought back to Earth in 2023. Bennu is currently more than 200 million miles, or 321 million kilometres, from Earth. Osiris-Rex launched from Cape Canaveral Air Force Station in Florida in September 2016.
Follow RTT